Signaling a link between interferon and the traits of Down syndrome

von Kirsammer, Gina, Crispino, John D
Veröffentlicht in eLife (2016)

Embryonic signaling in melanoma: potential for diagnosis and therapy

von Strizzi, Luigi, Hardy, Katharine M., Kirsammer, Gina T., Gerami, Pedram, Hendrix, Mary J.C.
Veröffentlicht 2011

Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation

von Goldenson, Benjamin, Kirsammer, Gina, Stankiewicz, Monika J., Wen, Qiang Jeremy, Crispino, John D.
Veröffentlicht in Blood (2015)

Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome

von Malinge, Sébastien, Bliss-Moreau, Meghan, Kirsammer, Gina, Diebold, Lauren, Chlon, Timothy, Gurbuxani, Sandeep, Crispino, John D.
Veröffentlicht 2012

Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome

von Kirsammer, Gina, Jilani, Sarah, Liu, Hui, Davis, Elizabeth, Gurbuxani, Sandeep, Le Beau, Michelle M., Crispino, John D.
Veröffentlicht 2008

Melanoma Tumor Cell Heterogeneity: A Molecular Approach to Study Subpopulations Expressing the Embryonic Morphogen Nodal

von Seftor, Elisabeth A., Seftor, Richard E.B., Weldon, Don, Kirsammer, Gina T., Margaryan, Naira V., Gilgur, Alina, Hendrix, Mary J.C.
Veröffentlicht 2014

Subsets of ATP-Sensitive Potassium Channel (K(ATP)) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression

von Bodenstine, Thomas M., Vaidya, Kedar S., Ismail, Aimen, Beck, Benjamin H., Diers, Anne R., Edmonds, Mick D., Kirsammer, Gina T., Landar, Aimee, Welch, Danny R.
Veröffentlicht 2011

Nodal signaling promotes a tumorigenic phenotype in human breast cancer

von Kirsammer, Gina, Strizzi, Luigi, Margaryan, Naira V., Gilgur, Alina, Hyser, Matthew, Atkinson, Janis, Kirschmann, Dawn A., Seftor, Elisabeth A., Hendrix, Mary J.C.
Veröffentlicht in Semin Cancer Biol (2014)

USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism

von Melo-Cardenas, Johanna, Xu, Yuanming, Wei, Juncheng, Tan, Can, Kong, Sinyi, Gao, Beixue, Montauti, Elena, Kirsammer, Gina, Licht, Jonathan D., Yu, Jindan, Ji, Peng, Crispino, John D., Fang, Deyu
Veröffentlicht in Blood (2018)